EP1664727A1 - Vorrichtung und verfahren zur automatisierten durchführung v on laborarbeitsschritten - Google Patents
Vorrichtung und verfahren zur automatisierten durchführung v on laborarbeitsschrittenInfo
- Publication number
- EP1664727A1 EP1664727A1 EP04787010A EP04787010A EP1664727A1 EP 1664727 A1 EP1664727 A1 EP 1664727A1 EP 04787010 A EP04787010 A EP 04787010A EP 04787010 A EP04787010 A EP 04787010A EP 1664727 A1 EP1664727 A1 EP 1664727A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- station
- unit
- tissue samples
- sample
- media
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract description 14
- 239000007788 liquid Substances 0.000 claims abstract description 43
- 239000012528 membrane Substances 0.000 claims description 66
- 239000000126 substance Substances 0.000 claims description 38
- 238000012360 testing method Methods 0.000 claims description 28
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 26
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 24
- 239000001301 oxygen Substances 0.000 claims description 24
- 229910052760 oxygen Inorganic materials 0.000 claims description 24
- 238000002474 experimental method Methods 0.000 claims description 19
- 230000008859 change Effects 0.000 claims description 14
- 230000000694 effects Effects 0.000 claims description 14
- 229910052757 nitrogen Inorganic materials 0.000 claims description 14
- 238000005259 measurement Methods 0.000 claims description 10
- 235000015097 nutrients Nutrition 0.000 claims description 9
- 239000003153 chemical reaction reagent Substances 0.000 claims description 6
- 238000002347 injection Methods 0.000 claims description 6
- 239000007924 injection Substances 0.000 claims description 6
- 238000012432 intermediate storage Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 3
- 238000007877 drug screening Methods 0.000 claims description 2
- 230000007831 electrophysiology Effects 0.000 claims description 2
- 238000002001 electrophysiology Methods 0.000 claims description 2
- 238000001531 micro-dissection Methods 0.000 claims description 2
- 230000035778 pathophysiological process Effects 0.000 claims description 2
- 230000035790 physiological processes and functions Effects 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 238000010200 validation analysis Methods 0.000 claims description 2
- 238000000386 microscopy Methods 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 description 47
- 239000002609 medium Substances 0.000 description 46
- 210000004027 cell Anatomy 0.000 description 24
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 9
- 229930195725 Mannitol Natural products 0.000 description 9
- 239000006481 glucose medium Substances 0.000 description 9
- 239000000594 mannitol Substances 0.000 description 9
- 235000010355 mannitol Nutrition 0.000 description 9
- 230000005540 biological transmission Effects 0.000 description 8
- 230000000295 complement effect Effects 0.000 description 8
- 238000012545 processing Methods 0.000 description 7
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 229940000406 drug candidate Drugs 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 238000002073 fluorescence micrograph Methods 0.000 description 4
- 230000000971 hippocampal effect Effects 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 230000000302 ischemic effect Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000013537 high throughput screening Methods 0.000 description 3
- 230000000366 juvenile effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 201000006474 Brain Ischemia Diseases 0.000 description 2
- 206010008120 Cerebral ischaemia Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000007946 glucose deprivation Effects 0.000 description 2
- 210000005003 heart tissue Anatomy 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 229920006008 lipopolysaccharide Polymers 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 238000012910 preclinical development Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 238000004971 IR microspectroscopy Methods 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000001746 atrial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000007675 cardiac surgery Methods 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000004624 confocal microscopy Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002692 disease related effect Effects 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000012362 drug development process Methods 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 238000002060 fluorescence correlation spectroscopy Methods 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 210000001320 hippocampus Anatomy 0.000 description 1
- 238000012750 in vivo screening Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 1
- 230000016273 neuron death Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 230000007310 pathophysiology Effects 0.000 description 1
- 238000011176 pooling Methods 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/02—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor using a plurality of sample containers moved by a conveyor system past one or more treatment or analysis stations
- G01N35/028—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor using a plurality of sample containers moved by a conveyor system past one or more treatment or analysis stations having reaction cells in the form of microtitration plates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
- G01N1/31—Apparatus therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N2035/00178—Special arrangements of analysers
- G01N2035/00326—Analysers with modular structure
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/02—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor using a plurality of sample containers moved by a conveyor system past one or more treatment or analysis stations
- G01N35/04—Details of the conveyor system
- G01N2035/0401—Sample carriers, cuvettes or reaction vessels
- G01N2035/0418—Plate elements with several rows of samples
- G01N2035/0422—Plate elements with several rows of samples carried on a linear conveyor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/02—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor using a plurality of sample containers moved by a conveyor system past one or more treatment or analysis stations
- G01N35/04—Details of the conveyor system
- G01N2035/046—General conveyor features
- G01N2035/0467—Switching points ("aiguillages")
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/0099—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor comprising robots or similar manipulators
Definitions
- the present invention relates to a device for the automated implementation of laboratory work steps on line or tissue samples, which has a plurality of modular stations, each carrying out at least one work step in a total sequence of work steps, and at least one conveyor unit for conveying sample containers to and between the stations ,
- WO 02/49761 proposes an automated laboratory system, in particular for carrying out the PCR method.
- the device comprises a plurality of modular stations, each of which carries out at least one work step in a total sequence of work steps, and a modular station which passes material to another station without human intervention.
- DE 198 53 184 A1 discloses a device for conveying a carrier element, in particular a titer plate, which has a plurality of sample wells to and between storage and / or processing stations, with a linear and in particular linearly connecting a loading and / or storage unit with at least one processing station Conveyor unit for transporting the carrier element, the processing station being equipped in a modular manner with at least one functional unit designed to carry out an automatable processing function on the carrier element or its test troughs, and for transferring a carrier element between the conveyor unit and functional unit, the processing station has a pivoting device which has at least one turntable or rotating arm , which is designed such that, in response to an electronic control signal, a support element held by the pivoting device by a predetermined angle by a rotation pivoted and can be transferred from the swivel device to an adjacent unit by moving.
- the known laboratory automation devices are less suitable for handling line or tissue samples, since the cultivation and processing of line and tissue samples requires special conditions over a longer period of time. It is therefore an object of the present invention to provide a device for the automated execution of laboratory work steps on cell or tissue samples, with which these samples can also be cultivated over a longer period of time.
- a device for the automated execution of laboratory work steps on line or tissue samples which has a plurality of modular stations, each carrying out at least one work step in a total sequence of work steps, and at least one conveyor unit for conveying samples to and between the stations and is characterized in that it has at least one station for automatically changing liquid media in the sample containers (media changing station).
- the laboratory work steps can be part of complex and highly complex test procedures.
- the device according to the invention has several modular stations, which can be known automatic pipetting, dosing or analysis machines, such as are described for example in WO 02/49761 or DE 198 53 184.
- the conveyor unit disclosed in DE 198 53 184 is suitable as a conveyor unit for conveying sample containers to and between the stations.
- the device according to the invention preferably comprises a
- Sample injection station at least one incubator station, one
- the cell or tissue samples for example juvenile cell tissue samples, in particular juvenile brain tissue samples (for example as hippocampus tissue sections), but also heart or liver tissue samples, such as cardiac atrial sections, are introduced into the device according to the invention in the sample introduction station.
- Sample containers in the form of plates with one or more recesses, which can contain membrane inserts, the plates each having a cover plate.
- Corresponding sample containers are commercially available, for example, as so-called 6-hole plates (also multi-dishes) and are used as tissue culture plates. These plates consist of a base plate and a removable cover. The base plate contains six wells. A membrane insert can be inserted into each recess.
- the bottom of which is designed as a membrane, for example in the form of a glass frit.
- the membrane inserts are loaded with tissue samples, especially manually.
- the tissue samples can be hippocampal sections from juvenile rats or heart or liver sections. Both animal and human tissue samples can be used.
- the device according to the invention provides a sample container at the sample introduction station on request by the operator, the recesses of which are already filled with a desired medium in a suitable amount.
- the sample container preferably contains water, in particular bidistilled water, between the wells in order to set a desired atmospheric humidity in the container.
- the tissue sections are then placed in the membrane inserts, and the sample container is then automatically transferred to the conveyor unit of the device.
- the device according to the invention had already taken an empty sample container from a storage container, for example, and filled the wells with the desired medium in a suitable amount and, if desired, the space between the wells with water in the media changing station.
- the multishell can then be equilibrated in an incubator station, in particular an oxygen incubator station, before being made available at the sample introduction station. This happens automatically for a predetermined period of time.
- the device can take over the empty sample container at the sample introduction station instead of from a storage container.
- the sample container which is preferably designed as a multishell, is then conveyed by the conveyor unit, for example, to an incubation station and stored there under controlled conditions (for example temperature and gas composition).
- the device according to the invention comprises at least two different incubator stations, an oxygen incubator station and a nitrogen incubator station.
- the climatic conditions in the oxygen incubator can be, for example, 95% air and 5% CO 2 at 36 ° C, the climatic conditions in the nitrogen incubator 95% N 2 and 5% CO 2 at 36 ° C.
- the media used for storing the samples must be changed regularly.
- the sample containers are conveyed from the conveyor unit to the media changing station.
- the media changing station can have a unit for removing a liquid medium from the wells of the plate of a sample container and a unit for adding one or more liquid media into the wells of the plate of the sample container. Since the sample containers can be provided with a cover plate, the media changing station can also comprise a unit for removing and fitting such a cover plate.
- the media change station can therefore additionally be equipped with a unit for removing and inserting the membrane inserts from the recesses in the plate of a sample container.
- the media changing station has a unit for mixing liquid media in the recesses of a plate of a sample container.
- the media change station therefore preferably works as follows:
- a sample container preferably a multi-tray, is transferred from the conveyor unit of the device according to the invention to the media changing station.
- the media change station automatically recognizes whether the sample container has a cover plate. If the sample container has a cover plate, this is removed by the unit for removing the cover plate. This can be done, for example, by a robot gripper that can be used with a pair of pliers to grip the cover plate or, for example equipped with a suction device for suctioning the cover plate by means of vacuum.
- the membrane inserts are then automatically removed from the recesses in the plate of the sample container.
- This can be done, for example, by robot grippers that can grip one or more of the membrane inserts simultaneously or one after the other and can remove them from the recesses.
- the robot gripper can have a link that engages in the membrane inserts and spreads gripping elements apart there.
- the unit for removing the membrane inserts preferably has as many grippers as the sample containers used have membrane inserts so that the unit can grip and remove all membrane inserts of a sample container at the same time.
- the unit for removing and inserting the membrane inserts should advantageously be able to selectively remove only one of the several membrane inserts from a sample container, so that, for example, samples identified as unusable can be sorted out during the experiment. This also enables samples from different origins, for example, to be mixed (pooled) in a sample container during an ongoing experiment.
- the media changing station also has a unit for the intermediate storage of membrane inserts under controlled conditions.
- This can be, for example, a multi-dish which contains suitable nutrient medium in the wells at a desired temperature.
- the unit for removing the membrane inserts can then insert the membrane inserts, which are removed from the sample container that has been transferred to the media changing station, into the recesses of the multi-dish, so that the tissue samples only have to remain separated from a nutrient medium for a short time.
- the device according to the invention can furthermore have a unit for removing liquid medium from membrane inserts.
- a unit for removing liquid medium from membrane inserts can be, for example, a filter paper, a fabric or a sponge on which the membrane inserts are set down and dried before being inserted into or after being removed from the unit for temporarily storing the membrane inserts.
- the membrane inserts After the membrane inserts have been removed from the plate of a sample container, the latter is conveyed in the media changing station to a unit for removing the liquid medium from the recesses of the plate of the sample container. This can be done, for example, using an automatic robot gripper or an assembly line. Alternatively, in the case of a stationary sample container, the unit for removing the membrane inserts can be exchanged for the unit for removing the liquid medium.
- the liquid medium can be removed from the wells of the plate, for example, by automatically tipping the liquid medium out of the wells or by suctioning off the liquid medium. It has proven to be advantageous if the plate is inclined, for example, by approximately 45 ° to remove the liquid medium, and the medium is then suctioned off. As a result, the medium can be removed from the depressions largely without residue.
- the suction can take place, for example, by means of one or more pipes which automatically sink into the recesses from above and suck off the medium by means of a pump.
- the unit for removing the liquid medium preferably has as many tubes for suction as the sample container used has depressions so that the medium can be sucked out of all the depressions of the sample container used at the same time. It may also be desirable for the liquid medium removal unit to have several different suction tubes for each well of the sample container, which can optionally be used for suction, so that different media can be collected separately from one another, for example in different collecting containers.
- the medium changing station can have several units for removing the liquid medium, which are automatically selected depending on the liquid medium that is to be removed from the sample container in order to collect different liquid media in different collecting containers separately from one another.
- the unit for adding one or more liquid media into the wells of the sample container is conveyed further to a unit for adding one or more liquid media into the wells of the sample container.
- a unit for adding one or more liquid media can be done either by automatically conveying the sample container, for example by a robot gripper, or by means of an assembly line.
- the unit for removing the liquid medium can be exchanged for the unit for adding one or more liquid media.
- the unit for adding one or more liquid media can be, for example, a pipetting unit with which a predetermined amount of one or more liquid media is introduced from one or more storage containers into a recess in the sample container.
- the unit can have one or more corresponding pipetting devices in order to be able to fill several different liquid media into the wells without a pipetting unit coming into contact with different media.
- the addition can take place simultaneously or in succession.
- the unit can also have as many pipetting units or combinations of pipetting units as the sample containers used have depressions in order to be able to fill all the depressions of a sample container at the same time. Alternatively, the unit can have fewer pipetting units or combinations of pipetting units than the sample container has depressions. In this case, the wells of a sample container are filled one after the other.
- the media changing station of the device according to the invention additionally has a unit for mixing the liquid media in the recesses of the sample container.
- This can be, for example, stirrers which engage in the depressions from above and mix the introduced liquid media by stirring.
- it can preferably be a vibrating table on which the sample containers are automatically placed. The various liquid media in the wells of the sample container are then mixed by shaking the container.
- the unit for inserting the membrane inserts After adding the liquid medium or the liquid media into the wells of the sample container, the unit for inserting the membrane inserts reinserts them into the wells of the sample container. If necessary, the membrane inserts are removed from the intermediate storage unit for this purpose and, if desired, cleaned from the membrane inserts by the liquid medium removal unit.
- the device according to the invention inserts the membrane inserts in such a way that no air bubbles form between the surface of the filled liquid medium and the underside of the membrane insert, since these form the Exchange of substances between the medium and, for example, the tissue sections on the surface of the membrane could hinder.
- the cover plate After inserting the membrane inserts into the wells of the sample container, the cover plate is possibly replaced and the multiplate is returned from the media change station to the conveyor unit, which automatically conveys the sample container to the next modular station, for example an incubator station.
- the cell or tissue samples can, for example, be exposed to disease-simulating conditions in order to then examine the effects of these conditions on the samples and / or the influence of test substances on the samples under these conditions.
- a nutrient medium is exchanged for another medium that does not contain the nutrients required by the tissue, in order to simulate a nutrient deficiency.
- the samples can also be incubated in a nitrogen incubator, for example, instead of in an oxygen incubator, in order to simulate an oxygen deficiency.
- one or more test substances can be added to the liquid media in the wells of the sample containers.
- the station for adding reagents is preferably coupled to the media changing station in order to avoid unnecessary work steps.
- the desired substance can then be introduced in a suitable quantity into the wells of the sample container, for example by means of an automatic pipette.
- the substances added can, for example, also be specific substances for inducing or simulating different disease-related events (for example lipopolysaccharides (LPS) and / or specific cytokines for inducing inflammatory events).
- LPS lipopolysaccharides
- cytokines for inducing inflammatory events.
- molecular biological tools e.g. small interference RNA (siRNA) or antisense sequences
- molecular biological constructs e.g. viral vectors
- a substance which supports the recording of measurement data of the cell tissue samples can optionally be added from the station for adding reagents to the wells of the sample containers.
- a substance can be, for example, propidium iodide (PI), which is suitable for staining nucleic acids.
- PI propidium iodide
- Appropriately stained samples can then be examined in the data acquisition station using fluorescence microscopy.
- markers / readouts for example, specific apoptosis markers, proliferation markers, cellular differentiation markers and fluorescence-labeled antibodies are suitable for the visualization of distinct proteins.
- the device according to the invention preferably also includes a data acquisition station in which, for example, a microscope unit (e.g. a confocal, non-confocal or Infrared microscopy unit) relevant data of the samples can be recorded at the beginning, during or at the end of the overall sequence of work steps.
- a microscope unit e.g. a confocal, non-confocal or Infrared microscopy unit
- relevant data of the samples can be recorded at the beginning, during or at the end of the overall sequence of work steps.
- transmission images and / or fluorescence images of corresponding tissue sections can be taken under the microscope and / or after staining with PI.
- a comparison of the different recordings before, during and after the corresponding treatment steps then enables the operator to determine whether and, if appropriate, to what extent the test substances used and / or changes in the incubation conditions have effects on the tissue cultures.
- the transmission microscope unit can take transmission pictures fully automatically. For this purpose, a picture of the complete membrane insert is first made and the position of the individual tissue sections in a membrane insert is automatically recognized by suitable software. The individual tissue sections are then individually enlarged to record the transmission images. The same can be done for the acquisition of the fluorescence images.
- Suitable data acquisition stations can be selected by the person skilled in the art depending on the experiment carried out and the markers used.
- the sample containers are preferably conveyed by the conveyor unit to a sample ejection station and collected there, for example, in order to later be able to be either disposed of or recycled.
- the device according to the invention can also have several, for example two, sample ejection stations for sample containers, for example with different liquid media, if these media are to be collected and disposed of separately from one another.
- the device according to the invention has a combination of the following stations: a sample introduction station in which cell tissue samples are introduced manually into membrane dishes which are located in depressions of a multi-dish, the depressions containing a nutrient medium for the cell tissue samples, an oxygen incubator station in which the Cell tissue samples are cultured, a media change station in which the nutrient medium in the multi-dishes is changed after predetermined time intervals, a reagent addition station in which one or more test substances, the effects of which on the cell tissue samples are to be tested and / or, if appropriate, one or more substances which increase the uptake Support of measurement data of the cell tissue samples, into which wells of the multi-dishes are added, optionally a nitrogen incubator station, in which the cell tissue samples are additionally incubated as needed in the course of the experiment t, a data acquisition station in which measurement data of the cell tissue samples are recorded, for example before and after addition of a test substance and / or cultivation in the nitrogen incubator, in order to determine their influence
- the device according to the invention has the advantage that, for example, tissue sections can be cultivated fully automatically and the effects of test substances and disease-simulating conditions on these tissue sections can be examined.
- the device according to the invention thus enables functional, tissue-based screening, in particular on the basis of disease-related effects. This overcomes a bottleneck between the very fast HTS processes, which deliver a large number of possible drug candidates, and the comparatively slow and, in particular, costly in vivo tests.
- the present invention thus also relates to the use of the device according to the invention for carrying out investigations of chemical, biological and / or physical influences on physiological or pathophysiological processes on samples such as cell tissue samples.
- the device can be used to test the effect of substances on samples, preferably on cell tissue samples. Corresponding uses are described, for example, with reference to vital mammary heart tissue cells kept ex vivo in DE 103 22 986.8 from KeyNeurotek AG.
- a method for testing the effect of substances on samples preferably on cell tissue samples, which comprises introducing samples into a device according to the invention and evaluating measurement data recorded in the data acquisition station.
- This method has the particular advantage that only the samples have to be prepared manually and the measurement data have to be evaluated manually.
- the laborious, time-consuming and cost-intensive intermediate steps, even of the most complex test sequences, are carried out fully automatically by the device according to the invention. A large number of different samples and test substances can therefore be examined simultaneously.
- Another advantage of the device according to the invention is its modular structure, which makes it possible, depending on the course of the desired experiment, to exchange individual modular stations for others, or the device, for example to increase capacity with additional incubators or e.g. can also be provided with an additional media change station.
- the device according to the invention is not subject to any capacity limits, since its capacity can be increased at any time by adding further modular stations.
- FIG. 1 shows schematically a top view of a possible embodiment of the device according to the invention.
- Figure 2 shows the perspective view of another possible embodiment of the device according to the invention.
- FIG. 1 and 2 show a sample injection station 1, two oxygen incubation stations 2 and 2 ", a nitrogen incubator station 3, a media change station 4, a data acquisition station 5, a sample container supply station 6 and (only in FIG. 1) two sample discharge stations 7 and 7 'and a conveyor unit 8 for conveying the sample containers to and between the stations.
- the use of the device according to the invention for screening possible active substances against cerebral ischemia is described by way of example below.
- Normal brain functions depend largely on the constant supply of glucose and oxygen.
- An interruption in cerebrospinal blood flow due to a stroke, brief heart failure or as a side effect of cardiac surgery quickly leads to ischemic conditions in the brain and then neuronal cell death.
- hippocampal sections can first be cultivated according to known protocols and then exposed to ischemic conditions through oxygen and glucose deprivation. Damage to neuronal cells from these conditions can then e.g. can be visualized by the intracellular fluorescence of added propidium iodide (Pl), which is only incorporated into damaged cells.
- Pl propidium iodide
- a possible positive effect of substances to be tested on the ability of neuronal cells to survive ischemic conditions is determined in a comparative experiment under the same conditions with simultaneous addition of the test substance to the sewing medium.
- the laboratory work steps required for this can be carried out by the device according to the invention as follows, for example.
- First, empty multishells with membrane inserts inserted into the depressions are introduced into the device via the sample introduction station 1.
- the conveyor unit 8 conveys the multishells to the media changing station 4, in which bidistilled water between the wells and glucose medium is filled into all the wells of the multishells.
- the multishells are conveyed by the conveyor unit 8 into an oxygen incubator 2 or 2 ', where they remain between 20 minutes and 24 hours for equilibration.
- the multishells are then conveyed from the oxygen incubator 2 or 2 'to the sample introduction station 1.
- the membrane inserts of the multi-shells are loaded by the operator with hippocampal sections that were previously prepared manually.
- the conveyor unit 8 then conveys the loaded multi-dishes back into an oxygen incubator 2 or 2 '.
- the multishells are preferably marked, for example with a barcode, which can then be read at any time by the conveyor unit and also by the various stations of the device according to the invention and compared with the database.
- the hippocampal sections are cultivated in an oxygen incubator 2 or 2 'for a period between six hours and 13 days or longer. During this dwell time, cyclic media changes are carried out (e.g. changing the glucose medium). For this purpose, the multi-dishes are conveyed to the media changing station 4 at intervals of 60 to 72 hours and back into the incubator after the media has been changed. Cultures are cultivated until the operator requests them for inspection, usually after six to 13 days.
- the samples are pre-checked.
- a multishell is conveyed from an oxygen incubator 2 or 2 'to the data acquisition station 5. There, transmission images of the complete membrane inserts and the individual sections of a membrane insert are made in a microscope unit. The multishell is then conveyed back into an oxygen incubator 2 or 2 '.
- the individual tissue sections are then evaluated on the basis of the transmission recordings and an experiment specific is assigned to each individual membrane insert of the multishells and communicated to the device according to the invention, for example, via a computer terminal.
- the membrane inserts of the multi-dishes are either removed if they have been identified as unsuitable, or they are put together again in multi-dishes, such membrane inserts which are to be subjected to the same cultivation conditions being combined in one multi-dish.
- This "pooling" can take place, for example, in the media changing station by means of the unit for removing and inserting membrane inserts from multi-shells and the intermediate storage of multi-shells in the unit for the intermediate storage of membrane inserts under controlled conditions.
- the database of the device is updated accordingly, so that the individual samples in the multishells can be clearly assigned even after the membrane inserts have been pooled.
- each membrane insert is assigned, for example, one of three possible conditions via the experiment specifics:
- OTD oxygen and glucose deprivation
- the individual conditions can be further specified, e.g. by specifying the type and amount of the test substance to be used, the duration of the OGD, etc.
- the multishells with membrane inserts which are intended for condition 2 or condition 3, are conveyed from the conveyor unit 8 to the media changing station 4. There, the glucose medium is exchanged for a glucose / test substance medium, and the multishells are then conveyed back into an oxygen incubator 2 or 2 '.
- empty multishells without membrane inserts are also introduced into the device either via the sample container supply station 6 or via the sample introduction station 1 and conveyed from the conveyor unit 8 to the media changing station 4.
- Exactly the number of new multi-shells is introduced which corresponds to the number of multi-shells which contain membrane inserts for the upcoming experiment, which are assigned to condition 1 or condition 2.
- a system-internal complementary assignment of the new multi-shells takes place, with exactly one newly introduced multi-shell being uniquely assigned to one multi-shell, which is for the upcoming one Experiment contains membrane inserts that are intended for condition 1 or condition 2.
- double-distilled water is filled between the wells of the newly introduced multi-dishes.
- a mannitol medium is placed in those wells of the newly introduced multishells in which there are membrane inserts on the complementary multishell intended for condition 1, and a mannitol / test substance medium in those wells of the newly introduced multishells in which there are complementary multi-shell membrane inserts, which are intended for condition 2, filled.
- the newly introduced multishells are then conveyed by the conveyor unit 8 into a nitrogen incubator 3, where they are equilibrated between 20 minutes and 24 hours.
- those multishells containing the membrane inserts with the tissue sections intended for condition 1 or condition 2 and the respective complementary multishells with the mannitol medium are conveyed from the conveyor unit 8 to the media change station 4.
- the membrane inserts, which are intended for condition 1 or condition 2 are converted from the multishells with the glucose medium into the complementary multishells with the mannitol medium.
- the multishells with the mannitol medium are conveyed to the OGD in the nitrogen incubator 3 and the multishells with the glucose medium in an oxygen incubator 2 or 2 '.
- the multishells with the mannitol medium remain in the nitrogen incubator 3, for example, for five to 90 minutes or longer, depending on the experiment specificity.
- the membrane inserts, which are intended for condition 1 or condition 2 are converted from the multishells with the mannitol medium into the complementary wells of the complementary multishells with the glucose medium, and the multishells with the glucose medium are transferred from the delivery unit 8 into an oxygen incubator 2 or 2 'promoted.
- the empty multi-dishes with the mannitol medium are discharged via the sample ejection station 7 or 7 '.
- Multishells with membrane inserts which are intended for condition 2 or condition 3 are conveyed from conveyor unit 8 to incubator station 4 approximately one hour after OGD and in those wells of the multishell which contain membrane inserts for condition 2 or condition 3, a media change with glucose medium is carried out.
- the multi-dishes are then conveyed into an oxygen incubator 2 or 2 'by incubating for a period of between two and 72 hours.
- the multishell is conveyed from the conveying unit 8 from an oxygen incubator 2 or 2 'to the media changing station 4 approximately two hours before the data acquisition, and propidium iodide (PI) is added to the wells of the multishell in a predetermined concentration.
- PI propidium iodide
- the multi-dishes are returned to an oxygen incubator 2 or 2 'and remain there for about two hours.
- Pl can again be added in the media changing station 4 in the same or a different concentration to the recesses of the multishell.
- the multishells are then conveyed to the data acquisition station and automatically transferred to the microscope unit there. There, transmission and fluorescence images of the complete membrane insert and the individual sections of a membrane insert are made under the microscope.
- the multishells are then taken over from the data acquisition station 5 by the conveyor unit 8 and, depending on the medium, are discharged via a sample ejection station 7 or 7 '.
- the experiment can be evaluated manually by the operator using the transmission and fluorescence images.
- the present invention is not limited to the above embodiment.
- the device can be supplemented with additional stations or individual stations can be exchanged for others in order to adapt them to a corresponding test sequence.
- the device according to the invention enables a large number of test substances to be tested sequentially or in parallel with little manual effort for their effect on a tissue sample under normal conditions or under disease-simulating conditions in vitro.
- the preclinical development of pharmaceuticals or the preclinical development of potential pharmaceuticals is significantly accelerated, so that they can be carried out more cost-effectively for a large number of substances.
- constant test conditions are ensured by the automated work steps, so that the measurement data obtained are highly reproducible and meaningful.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10344284A DE10344284A1 (de) | 2003-09-24 | 2003-09-24 | Vorrichtung und Verfahren zur automatisierten Durchführung von Laborarbeitsschritten |
PCT/EP2004/010755 WO2005031313A1 (de) | 2003-09-24 | 2004-09-24 | Vorrichtung und verfahren zur automatisierten durchführung von laborarbeitsschritten |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1664727A1 true EP1664727A1 (de) | 2006-06-07 |
Family
ID=34384247
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04787010A Withdrawn EP1664727A1 (de) | 2003-09-24 | 2004-09-24 | Vorrichtung und verfahren zur automatisierten durchführung v on laborarbeitsschritten |
Country Status (6)
Country | Link |
---|---|
US (1) | US20070005169A1 (zh) |
EP (1) | EP1664727A1 (zh) |
JP (1) | JP2007506419A (zh) |
CN (1) | CN1856701A (zh) |
DE (1) | DE10344284A1 (zh) |
WO (1) | WO2005031313A1 (zh) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7860727B2 (en) * | 2003-07-17 | 2010-12-28 | Ventana Medical Systems, Inc. | Laboratory instrumentation information management and control network |
US8719053B2 (en) * | 2003-07-17 | 2014-05-06 | Ventana Medical Systems, Inc. | Laboratory instrumentation information management and control network |
DE102005054206B4 (de) * | 2005-11-14 | 2010-07-15 | Roth, Willi, Prof. Dr. | Verfahren und Vorrichtung zum automatisierten Bearbeiten von gepoolten Proben |
WO2007078842A1 (en) | 2005-12-19 | 2007-07-12 | Ventana Medical Systems, Inc. | Automated lean methods in anatomical pathology |
US7807108B2 (en) * | 2006-09-18 | 2010-10-05 | Leica Microsystems Cms Gmbh | Apparatus for receiving biological specimens |
DE102006049208A1 (de) * | 2006-10-18 | 2008-04-24 | Polysius Ag | Laborsystem |
US9874501B2 (en) * | 2006-11-24 | 2018-01-23 | Curiox Biosystems Pte Ltd. | Use of chemically patterned substrate for liquid handling, chemical and biological reactions |
WO2008063135A1 (en) | 2006-11-24 | 2008-05-29 | Agency For Science, Technology And Research | Apparatus for processing a sample in a liquid droplet and method of using the same |
EP1975595A1 (en) * | 2007-03-21 | 2008-10-01 | Diapath S.r.l. | Automatic processor for histological samples and its operation |
DE102007048684B4 (de) * | 2007-10-10 | 2010-09-09 | Polysius Ag | Laborsystem |
US10725020B2 (en) | 2007-11-14 | 2020-07-28 | Curiox Biosystems Pte Ltd. | High throughput miniaturized assay system and methods |
WO2013114217A1 (en) | 2012-02-05 | 2013-08-08 | Curiox Biosystems Pte Ltd. | Array plates and methods for making and using same |
GB2472236A (en) * | 2009-07-29 | 2011-02-02 | Iti Scotland Ltd | Apparatus for analysing microfluidic devices |
US9878328B2 (en) | 2010-07-23 | 2018-01-30 | Curiox Biosystems Pte Ltd. | Apparatus and method for multiple reactions in small volumes |
US9381524B2 (en) | 2011-11-08 | 2016-07-05 | Becton, Dickinson And Company | System and method for automated sample preparation |
CN102607914B (zh) * | 2012-03-08 | 2015-06-17 | 张晓东 | 翻转式细胞制片装置 |
US10545139B2 (en) | 2015-06-16 | 2020-01-28 | Curiox Biosystems Pte Ltd. | Methods and devices for performing biological assays using magnetic components |
CN105396537A (zh) * | 2015-11-25 | 2016-03-16 | 郑臣钏 | 一种多功能化工实验反应设备 |
TWI713536B (zh) * | 2016-06-15 | 2020-12-21 | 諾貝爾生物有限公司 | 用於生物熱反應的封蓋系統及其方法 |
EP4280260A3 (en) | 2017-04-05 | 2024-03-06 | Curiox Biosystems Pte Ltd. | Methods, devices, and apparatus for washing samples on array plates |
CN106967585B (zh) * | 2017-05-23 | 2024-03-12 | 湖州师范学院 | 用于核酸提取与检测的一体化设备 |
WO2020098957A1 (en) * | 2018-11-16 | 2020-05-22 | Aixinno Limited | A process module for an automated biology system |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4123660A1 (de) * | 1991-07-17 | 1993-01-21 | Jens Dr Bernhardt | Neue traegermaterialien fuer die zellkultur |
WO2000060361A2 (en) * | 1999-04-02 | 2000-10-12 | Sequenom, Inc. | Automated analysers |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0195088B1 (en) * | 1984-09-18 | 1992-12-09 | Sumitomo Electric Industries Limited | Apparatus for sorting cells |
JPS6174570A (ja) * | 1984-09-18 | 1986-04-16 | Sumitomo Electric Ind Ltd | 細胞選別装置 |
EP0255026A3 (en) * | 1986-07-23 | 1988-10-19 | Takeda Chemical Industries, Ltd. | Automatic analysis method and apparatus for enzyme reaction |
JPS6467177A (en) * | 1987-09-05 | 1989-03-13 | Akihiro Fujimura | Automatic apparatus for developing drug |
US4927545A (en) * | 1988-10-06 | 1990-05-22 | Medical Automation Specialties, Inc. | Method and apparatus for automatic processing and analyzing of blood serum |
JPH02150270A (ja) * | 1988-11-30 | 1990-06-08 | Sumitomo Electric Ind Ltd | 薬効検査装置 |
CA2063826A1 (en) * | 1989-07-18 | 1991-01-19 | Christian Pieler | Automated laboratory apparatus |
US5192506A (en) * | 1991-02-14 | 1993-03-09 | P B Diagnostic Systems, Inc. | Incubator port closure for automated assay system |
US5696887A (en) * | 1991-08-05 | 1997-12-09 | Biotek Solutions, Incorporated | Automated tissue assay using standardized chemicals and packages |
US5972694A (en) * | 1997-02-11 | 1999-10-26 | Mathus; Gregory | Multi-well plate |
US5985214A (en) * | 1997-05-16 | 1999-11-16 | Aurora Biosciences Corporation | Systems and methods for rapidly identifying useful chemicals in liquid samples |
US6699710B1 (en) * | 1998-02-25 | 2004-03-02 | The United States Of America As Represented By The Department Of Health And Human Services | Tumor tissue microarrays for rapid molecular profiling |
DE19853184A1 (de) * | 1998-11-19 | 2000-06-08 | Steiff Foerdertech | Vorrichtung zum Fördern eines Trägerelements |
AU2633100A (en) * | 1999-01-29 | 2000-08-18 | Genomic Instrumentation Services, Inc. | Robotic work station |
WO2001042796A1 (en) * | 1999-12-13 | 2001-06-14 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health & Human Services, The National Institutes Of Health | High-throughput tissue microarray technology and applications |
DK1363736T3 (da) * | 2000-12-18 | 2011-06-27 | Protedyne Corp | Ekstrudering af gelmateriale til gelelektroforese |
WO2002055201A2 (en) * | 2001-01-12 | 2002-07-18 | Scient Generics Ltd | Sample processing apparatus |
FR2820756B1 (fr) * | 2001-02-09 | 2004-01-23 | Daniel Attias | Incubateur et procede d'incubation menageant l'organisme mis a incuber |
US6673315B2 (en) * | 2001-06-29 | 2004-01-06 | Biomachines, Inc. | Method and apparatus for accessing a site on a biological substrate |
-
2003
- 2003-09-24 DE DE10344284A patent/DE10344284A1/de not_active Ceased
-
2004
- 2004-09-24 WO PCT/EP2004/010755 patent/WO2005031313A1/de active Application Filing
- 2004-09-24 EP EP04787010A patent/EP1664727A1/de not_active Withdrawn
- 2004-09-24 CN CNA2004800276779A patent/CN1856701A/zh active Pending
- 2004-09-24 JP JP2006527364A patent/JP2007506419A/ja active Pending
- 2004-09-24 US US10/573,448 patent/US20070005169A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4123660A1 (de) * | 1991-07-17 | 1993-01-21 | Jens Dr Bernhardt | Neue traegermaterialien fuer die zellkultur |
WO2000060361A2 (en) * | 1999-04-02 | 2000-10-12 | Sequenom, Inc. | Automated analysers |
Non-Patent Citations (1)
Title |
---|
See also references of WO2005031313A1 * |
Also Published As
Publication number | Publication date |
---|---|
DE10344284A1 (de) | 2005-05-04 |
WO2005031313A1 (de) | 2005-04-07 |
JP2007506419A (ja) | 2007-03-22 |
CN1856701A (zh) | 2006-11-01 |
US20070005169A1 (en) | 2007-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1664727A1 (de) | Vorrichtung und verfahren zur automatisierten durchführung v on laborarbeitsschritten | |
DE69115674T2 (de) | Apparat zur durchführung biochemischer reaktionen | |
DE69904726T2 (de) | Automatisches immunoassay-gerät mit flexiblem hebearm | |
DE69932607T2 (de) | Verfahren und vorrichtung zur erstellung eines arrays für schnelle molekulare profilidentifizierungen | |
DE60028352T2 (de) | Instrument zur herstellung von gewebe-arrays | |
EP0810428B1 (de) | Automatisierte Vorrichtung und Verfahren zum Messen und Bestimmen von Molekülen oder Teilen davon | |
DE602004010578T2 (de) | Vorrichtung und Verfahren zur Aufnahme von Tierzellenkolonien | |
AT401581B (de) | Automatisches analysengerät für patientenproben | |
DE68908807T2 (de) | Gerät zur Analyse von biologischen Flüssigkeiten. | |
DE10020704B4 (de) | Biochip zur Archivierung und labormedizinischen Analyse von biologischem Probenmaterial, Verfahren zu dessen Herstellung sowie dessen Verwendung in diagnostischen Verfahren | |
EP0819930A2 (de) | Verfahren und Vorrichtung zum Screening von Molekülen bezüglich ihres individuellen Bindungsverhaltens zu mindestens einem vorgegebenen Ligand | |
EP1882948A2 (de) | Vorrichtung zur Probenverarbeitung | |
DE60307645T2 (de) | Hoch-durchsatz assay zur messung von zellulären antworten mit hilfe von mikroarrays | |
DE19940749A1 (de) | Verfahren und Vorrichtung zur integrierten Synthese und Analyse von Polymeren | |
WO2002058850A1 (de) | Haltevorrichtung | |
DE102008057317A1 (de) | Vorrichtung und Verfahren zur Aufreinigung von Biomolekülen | |
DE60105675T2 (de) | Microarray sowie dafür geeignetes Herstellungs- und Aufgabestiftabstandskorrekturverfahren | |
EP2027447A1 (de) | Vorrichtung und verfahren zur automatisierten reproduzierbaren herstellung von auf objektträgern angeordneten zu untersuchenden zell- oder gewebeproben | |
DE202017101988U1 (de) | Automatisiertes System zur Kultivierung und Differenzierung pluripotenter Stammzellen | |
EP3532599A1 (de) | Vorrichtung und verfahren zur behandlung biologische zellen enthaltender proben | |
DE202017007583U1 (de) | Apparat zum Aufnehmen einer biologischen Probe | |
DE3346532A1 (de) | Verfahren zum steuern eines analysiergeraets fuer chemische analysen | |
EP2269028A2 (de) | Automatische vorrichtung zur durchführung von nachweisreaktionen und verfahren zur dosierung von reagenzien auf objektträgern | |
EP1718948B1 (de) | Verfahren zur herstellung festphasen-gebundener bioreagenzien | |
DE112016003660T5 (de) | Vorbereitung biologischer Probe zum Testen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20060303 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
17Q | First examination report despatched |
Effective date: 20060721 |
|
DAX | Request for extension of the european patent (deleted) | ||
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: ROEHNERT, PETER Inventor name: STRIGGOW, FRANK |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20100622 |